Samsung Biologics
207940.KS
#478
Rank
A$73.93 B
Marketcap
A$1,524
Share price
-1.45%
Change (1 day)
18.77%
Change (1 year)

EPS for Samsung Biologics (207940.KS)

EPS in 2026 (TTM): A$36.97

According to Samsung Biologics 's latest financial reports the company's current EPS (TTM) is A$37.75. In 2025 the company made an earnings per share (EPS) of A$27.98 an increase over its 2024 EPS that were of A$15.67.

EPS history for Samsung Biologics from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$36.9732.14%
2025A$27.9878.53%
2024A$15.6711.34%
2023A$14.082.67%
2022A$13.7183.43%
2021A$7.4749.14%
2020A$5.0126.39%
2019A$3.97-12.58%
2018A$4.54-320.64%
2017A-$2.06-46.78%
2016A-$3.86-105.09%
2015A$75.93-1089.67%
2014A-$7.67